Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Aptose Biosciences (APS) just unveiled an update.
On June 14, 2024, a press release was issued by the Registrant, detailing information that, as per the rules outlined, will not be considered officially “filed” under the Securities Exchange Act of 1934. This distinction implies that the content should not automatically be integrated into any legal filings unless explicitly referenced in such documents.
Find detailed analytics on APS stock on TipRanks’ Stock Analysis page.
